Shanghai kinetic medical Co., Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shanghai Kailitai Medical Technology Co., Ltd. is a high-end medical device group that integrates research and development, production, and sales of medical devices. It was established in Zhangjiang Torch Park, Pudong, Shanghai in 2005. At the beginning of its establishment, the company was committed to providing high-quality clinical treatment plans for patients with vertebral compression fractures caused by osteoporosis. Through continuous efforts, Kailitai took the lead in achieving the localization of compliant vertebral expansion balloon catheters in China, filling the gap at that time in China, breaking the technological monopoly of multinational corporations, greatly reducing product prices, and benefiting the majority of domestic patients. Since its establishment, Kailitai has maintained rapid growth, with products covering more than 1000 second level or above hospitals in China. In just a few years, its main products have occupied half of the entire domestic market and become a leader in this segmented field. The company's products have been awarded titles such as "National Key New Product", "Shanghai Key New Product", "Shanghai Independent Innovation Product", and "Shanghai Patent New Product", as well as honors such as the "Technology Innovation Fund for Small and Medium sized Enterprises", "Shanghai Science and Technology Progress Award", and "Silver Award of the 19th China International Industrial Expo" by the Ministry of Science and Technology. In 2017, Kailitai was recognized as a Shanghai Municipal Enterprise Technology Center by the Shanghai Municipal Commission of Economy and Information Technology. In 2018, it was recognized as a research and development center for multinational corporations by the Shanghai Municipal Commission of Commerce. In 2019, it was recognized as a "specialized, refined, and innovative" small giant enterprise by the Ministry of Industry and Information Technology of the People's Republic of China. At the same time, the products have successively obtained EU CE certification, US FDA 510K certification, and Japanese Ministry of Health certification. With excellent quality, they have gone abroad and have been clinically applied in many developed countries such as Europe and America, achieving large-scale sales. In June 2012, Kailitai was successfully listed on the Shenzhen Stock Exchange ChiNext (stock code: 300326), becoming the first orthopedic medical device enterprise to be listed on the domestic A-share market. After going public, capital operations were supported by market leverage, and through a combination of endogenous growth and external mergers and acquisitions, Kailitai entered its second period of rapid development. The company relies on a continuously strengthening research and development team, aiming at the development trend of high-end medical devices, adhering to the rolling development of products, and gradually realizing the identity transformation of products from technology following to technological innovation and leading. At the same time, the company has completed two high-quality mergers and acquisitions, further enhancing its market position and brand influence in the domestic medical equipment industry. In 2018, Kailitai acquired Ellience, LLC, an American orthopedic equipment company, prompting the company to explore new business segments in the orthopedic equipment field and integrate with the company's existing orthopedic industry, complementing each other, achieving a comprehensive layout of the enterprise in the orthopedic field. At present, the company's product line has covered fields such as orthopedics, spine, joints, trauma, sports medicine, and ear, nose, and throat. There are more than 60 types of products in total, with complete varieties and wide coverage, achieving the transformation and upgrading from traditional medical device enterprises to diversified high-end medical consumables platform groups. In 2020, the company acquired and controlled Guoyao Jienuo Medical Services Co., Ltd., adding a standardized, industrialized, and large-scale sterile product supply service platform. While ensuring the quality of medical sterilization, it can help hospitals reduce operating costs and improve the efficiency of regional medical resource allocation. After more than ten years of accumulation, the company has established ten mature technology platforms, covering fields such as polymer balloons, metal implant processing, active RF equipment and consumables, degradable materials, intelligent manufacturing robots, tissue engineering, etc. These R&D platforms will serve as a powerful technology reserve for the company, laying a solid foundation for promoting the development of Kailitai Technology, enhancing core competitiveness, and achieving the strategic goal of revitalizing enterprises through technology. |
| Headquarter | Shanghai |
| Establish Date | 3/31/2005 |
| Listed Code | 300326.SZ |
| Listed Date | 6/13/2012 |
| Chairman | Yuan Zheng. |
| CEO | Wang Zhengmin. |
| Website | www.kineticmedinc.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
